tiprankstipranks
Trending News
More News >
Ampio Pharmaceuticals (AMPE)
OTHER OTC:AMPE
US Market
Advertisement

Ampio Pharmaceuticals (AMPE) Technical Analysis

Compare
506 Followers

Technical Sentiment

Overall Consensus
Buy
9Bullish
3Neutral
4Bearish
Technical Analysis Consensus
Sell
3Bullish
3Neutral
4Bearish
Moving Average Consensus
Strong Buy
6Bullish
0Neutral
0Bearish
Ampio Pharmaceuticals’s (AMPE) Moving Averages Convergence Divergence (MACD) indicator is 0.02, suggesting Ampio Pharmaceuticals is a Sell.
Ampio Pharmaceuticals’s (AMPE) 20-Day exponential moving average is 0.08, while Ampio Pharmaceuticals’s (AMPE) share price is $0.16, making it a Buy.
Ampio Pharmaceuticals’s (AMPE) 50-Day exponential moving average is 0.10, while Ampio Pharmaceuticals’s (AMPE) share price is $0.16, making it a Sell.

Ampio Pharmaceuticals (AMPE) Pivot Points

Oct 13, 2025, 12:01 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.11
0.11
0.11
0.11
0.11
0.11
0.11
Fibonacci
0.11
0.11
0.11
0.11
0.11
0.11
0.11
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Ampio Pharmaceuticals (AMPE) Moving Averages

Oct 13, 2025, 12:01 AM
Period
Simple
Exponential
MA5
0.11Buy
0.11Buy
MA10
0.07Buy
0.09Buy
MA20
0.07Buy
0.08Buy
MA50
0.09Sell
0.10Sell
MA100
0.28Sell
0.42Sell
MA200
Ampio Pharmaceuticals’s (AMPE) 10-Day exponential moving average is 0.09, while Ampio Pharmaceuticals’s (AMPE) share price is $0.16, making it a Buy.
Ampio Pharmaceuticals’s (AMPE) 100-Day exponential moving average is 0.42, while Ampio Pharmaceuticals’s (AMPE) share price is $0.16, making it a Sell.
Ampio Pharmaceuticals’s (AMPE) stock price is $0.16 and Ampio Pharmaceuticals’s (AMPE) 50-day simple moving average is 0.09, creating a Sell signal.
Ampio Pharmaceuticals’s (AMPE) stock price is $0.16 and Ampio Pharmaceuticals’s (AMPE) 100-day simple moving average is 0.28, creating a Sell signal.

Ampio Pharmaceuticals (AMPE) Technical Indicators

Oct 13, 2025, 12:01 AM
Name
Value
Implied Action
RSI (14)
68.40
Neutral
STOCH (9,6)
95.36
Sell
STOCHRSI (14)
88.02
Sell
MACD (12,26)
0.02
Sell
ADX (14)
26.43
Neutral
Williams %R
-2.60
Sell
CCI (14)
85.83
Neutral
ATR (14)
0.02
-
Ultimate Oscillator
84.02
Buy
ROC
23.08
Buy
Ampio Pharmaceuticals’s (AMPE) Relative Strength Index (RSI) is 68.40, creating a Neutral signal.
Ampio Pharmaceuticals’s (AMPE) Trend Strength Indicator (ADX) is 26.43, creating a Neutral signal.
Ampio Pharmaceuticals’s (AMPE) Commodity Channel Index (CCI) is 85.83, creating a Neutral signal.
Ampio Pharmaceuticals’s (AMPE) Price Rate of Change (ROC) is 23.08, creating a Buy signal.

FAQ

Is AMPE a Buy, Hold, or Sell?
Based on AMPE’s technical indicators, AMPE is a Buy.
    What is AMPE’s RSI (14)?
    AMPE’s RSI (14) is 68.40, which suggests AMPE is a Neutral.
      What is AMPE’s MACD?
      AMPE’s MACD is 0.02, which suggests AMPE is a Sell.
        What is AMPE’s 5-day moving average?
        AMPE’s 5-day moving average is 0.11, which suggests AMPE is a Buy.
          What is AMPE’s 20-day moving average?
          AMPE 20-day moving average is 0.07, which suggests AMPE is a Buy.
            What is AMPE’s 50-day moving average?
            AMPE’s 50-day moving average is 0.09, which suggests AMPE is a Sell.
              What is AMPE’s 200-day moving average?
              Currently, no data Available
              What is AMPE’s Williams % R (14)?
              AMPE’s Williams % R (14) is -2.60, which suggests AMPE is a Sell.
                What is AMPE’s CCI (14)?
                AMPE’s CCI (14) is 85.83, which suggests AMPE is a Neutral.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis